Europe’s share of the world’s clinical trials shrinks: IQVIA
23 Oct 2024 //
FIERCE BIOTECH
Sygnature Discovery Names Amira Modi as COO
03 Oct 2024 //
CONTRACT PHARMA
Granules India gains ANDA approval for Trazodone tablets
09 Aug 2024 //
PRESS RELEASE
Supernus Announces Second Quarter 2024 Financial Results
06 Aug 2024 //
GLOBENEWSWIRE
IQVIA analytics unit powers earnings boost for $3.8B in Q2 revenue
23 Jul 2024 //
FIERCE BIOTECH
Velocity appoints ex-IQVIA and Science 37 Executive Mike Zaranek as CFO
16 Jul 2024 //
GLOBENEWSWIRE
IQVIA Named Leader In Medical Affairs And Regulatory Ops By Everest Group
11 Jul 2024 //
BUSINESSWIRE
China`s share of trials jumps, along with enrollment times: IQVIA report
10 Jul 2024 //
FIERCE BIOTECH
IQVIA Launches One Home Clinical Trial Technology Platform
12 Jun 2024 //
BUSINESSWIRE
IQVIA aims to solve site capacity problem with software platform
12 Jun 2024 //
FIERCE BIOTECH
IQVIA Institute: Innovative Therapies And Strong Pipeline To Combat Rise In
10 Jun 2024 //
BUSINESSWIRE
Weight-loss drug forecasts jump to $150 billion as supply grows
28 May 2024 //
REUTERS
US Medicines Spending Grew In 2023 As Access Offset COVID Decline
14 May 2024 //
BUSINESSWIRE
IQVIA CFO At BofA Healthcare Conference May 14
09 May 2024 //
BUSINESSWIRE
IQVIA Celebrates HBA Award Winners Stewart and Barnes
23 Apr 2024 //
BUSINESSWIRE
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Conference
06 Mar 2024 //
BUSINESSWIRE
IQVIA Publishes its 2023 Environmental, Social and Governance Report
26 Feb 2024 //
BUSINESSWIRE
Global Biopharma R&D Boasts Increased Funding
23 Feb 2024 //
BUSINESSWIRE
Clinical trial starts slowed to below pre-pandemic levels last year, IQVIA finds
22 Feb 2024 //
ENDPTS
IQVIA CFO Ron Bruehlman to Speak at Citi`s Unplugged Medtech Access Day
21 Feb 2024 //
BUSINESSWIRE
IQVIA quarterly results beat estimates on strong demand for research services
14 Feb 2024 //
REUTERS
IQVIA Named to Fortune® World`s Most Admired Companies™ List
06 Feb 2024 //
BUSINESSWIRE
IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
24 Jan 2024 //
BUSINESSWIRE
Global Medicine Spending to Reach $2.3 Trillion by 2028
17 Jan 2024 //
BUSINESSWIRE
IQVIA and Propel abandon merger after FTC probe and injunction
05 Jan 2024 //
ENDPTS
IQVIA hit by decision to uphold block of its DeepIntent buyout
30 Dec 2023 //
FIERCE PHARMA
US judge allows FTC to temporarily block IQVIA acquisition of DeepIntent
29 Dec 2023 //
REUTERS
IQVIA Enablement Named PM360 Trailblazer 2023 Supplier/Vendor of the Year
29 Nov 2023 //
BUSINESSWIRE
IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference
21 Nov 2023 //
BUSINESSWIRE
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes
15 Nov 2023 //
BUSINESSWIRE
New IQVIA report points to window of opportunity for the EU
26 Oct 2023 //
MEDICINESFOREUROPE
IQVIA and CEPI Collaborate to Advance the 100 Days Mission
11 Oct 2023 //
BUSINESSWIRE
IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023
09 Oct 2023 //
BUSINESSWIRE
IQVIA Appoints Richard Staub III President of Research & Development Solutions
25 Sep 2023 //
BUSINESSWIRE
IQVIA Named a Leader in Pharmacovigilance Solutions in IDC MarketScape Report
12 Sep 2023 //
BUSINESSWIRE
IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference
05 Sep 2023 //
BUSINESSWIRE
IQVIA and Propel to hold on deal close as FTC case proceeds
25 Jul 2023 //
ENDPTS
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023
06 Jul 2023 //
BUSINESSWIRE
IQVIA Launches RIM Smart Labeling to Deliver Intelligence-Driven Approach
26 Jun 2023 //
BUSINESSWIRE
IQVIA Launches RIM Smart Labeling for Global Label Management
26 Jun 2023 //
CONTRACT PHARMA
IQVIA & (RED) Announce Partnership to Support Laboratory System Strengthening
25 May 2023 //
BUSINESSWIRE
PD-1 R&D tapers off as new molecules capture interest: IQVIA
24 May 2023 //
FIERCE BIOTECH
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
18 May 2023 //
BUSINESSWIRE
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes
18 May 2023 //
BUSINESSWIRE
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman`s Association Rising Star Award
11 May 2023 //
BUSINESSWIRE
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
06 Apr 2023 //
BUSINESSWIRE
Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic
14 Mar 2023 //
BUSINESSWIRE
IQVIA Publishes its 2022 Environmental, Social and Governance Report
23 Feb 2023 //
BUSINESSWIRE
IQVIA Reports Q4 and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
10 Feb 2023 //
BUSINESSWIRE
IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies” Ranked #1
09 Feb 2023 //
BUSINESSWIRE
IQVIA partners with Alibaba Cloud to expand services in China
02 Feb 2023 //
FIERCE BIOTECH
IQVIA in Collaboration with Alibaba Cloud to Deliver Clinical Solutions in China
31 Jan 2023 //
BUSINESSWIRE
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
25 Jan 2023 //
BUSINESSWIRE
Global Market for Medicines to Rise to $1.9 Trillion by 2027
18 Jan 2023 //
BUSINESSWIRE
IQVIA and Clalit Health to launch prime site in Israel
11 Nov 2022 //
CLINICALTRIALSARENA
Dr. Reddy’s Labs partners with IQVIA for improving customer interaction service in India
28 Sep 2022 //
FINANCIAL EXPRESS
GSK, IQVIA team up on ‘Vaccine Track’ to spotlight shot trends across the US
10 Aug 2022 //
FIERCE PHARMA
GSK & IQVIA launch platform of US vaccination data, showing drop in adult rates
08 Aug 2022 //
ENDPTS
ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform.
08 Aug 2022 //
BUSINESS WIRE
IQVIA Appoints Dr. Christina Mack CSO of Real World Solutions
07 Jun 2022 //
BUSINESSWIRE